 Project Jefferson began in 1997 and was designed to reproduce a strain of genetically modified anthrax isolated by Russian scientists during the 1990s.The goal was to determine whether or not the strain was resistant to the commercially available U.S. anthrax vaccine.The project was disclosed in a September 4, 2001 article in "The New York Times".